We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

TDM of Generic Lopinavir/Ritonavir 200/50 mg

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00802334
Recruitment Status : Completed
First Posted : December 4, 2008
Last Update Posted : March 26, 2015
The Government Pharmaceutical Organization
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration